DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications-Reference-Cited by-同舟云学术

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

Published:2020-11-21 Issue:24 Volume:12 Page:25275-25293
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Xu Feng¹,He Lulu²,Zhan Xueqin³,Chen Jiexin⁴,Xu Huan⁵,Huang Xiaoling¹,Li Yangyi¹,Zheng Xiaohe¹,Lin Ling⁵,Chen Yongsong⁴

Affiliation:

1. Department of Respiratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China

2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

3. Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

4. Department of Endocrinology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China

5. Department of Rheumatology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD;Pharmacogenomics and Personalized Medicine;2024-06

2. A novel subtype based on driver methylation–transcription in lung adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2024-05-22

3. Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma;BMC Cancer;2024-01-23

4. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma;Scientific Reports;2024-01-04